Annual Operating Expenses
$15.35 M
-$12.30 M-44.49%
31 December 2023
Summary:
Aileron Therapeutics annual total operating expenses is currently $15.35 million, with the most recent change of -$12.30 million (-44.49%) on 31 December 2023. During the last 3 years, it has fallen by -$5.15 million (-25.12%). ALRN annual operating expenses is now -51.89% below its all-time high of $31.90 million, reached on 31 December 2018.ALRN Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$6.07 M
-$2.97 M-32.84%
30 September 2024
Summary:
Aileron Therapeutics quarterly total operating expenses is currently $6.07 million, with the most recent change of -$2.97 million (-32.84%) on 30 September 2024. Over the past year, it has increased by +$4.09 million (+207.08%). ALRN quarterly operating expenses is now -37.15% below its all-time high of $9.66 million, reached on 30 June 2018.ALRN Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALRN Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.5% | +207.1% |
| 3 y3 years | -25.1% | -10.6% |
| 5 y5 years | -51.9% | -23.3% |
ALRN Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -44.5% | at low | -32.8% | +207.1% |
| 5 y | 5 years | -51.9% | at low | -32.8% | +207.1% |
| alltime | all time | -51.9% | +19.1% | -37.1% | +207.1% |
Aileron Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.07 M(-32.8%) |
| June 2024 | - | $9.04 M(+25.5%) |
| Mar 2024 | - | $7.21 M(-1.3%) |
| Dec 2023 | $15.35 M(-44.5%) | $7.30 M(+269.3%) |
| Sept 2023 | - | $1.98 M(-5.0%) |
| June 2023 | - | $2.08 M(-47.9%) |
| Mar 2023 | - | $3.99 M(-15.2%) |
| Dec 2022 | $27.65 M(+3.9%) | $4.70 M(-27.4%) |
| Sept 2022 | - | $6.48 M(-19.4%) |
| June 2022 | - | $8.04 M(-4.5%) |
| Mar 2022 | - | $8.42 M(+23.5%) |
| Dec 2021 | $26.61 M(+29.8%) | $6.82 M(+0.4%) |
| Sept 2021 | - | $6.79 M(+13.0%) |
| June 2021 | - | $6.01 M(-14.0%) |
| Mar 2021 | - | $6.99 M(+66.7%) |
| Dec 2020 | $20.50 M | $4.19 M(-16.6%) |
| Sept 2020 | - | $5.03 M(+14.3%) |
| June 2020 | - | $4.40 M(-36.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $6.88 M(-6.4%) |
| Dec 2019 | $29.96 M(-6.1%) | $7.35 M(-7.2%) |
| Sept 2019 | - | $7.92 M(+7.3%) |
| June 2019 | - | $7.38 M(+0.9%) |
| Mar 2019 | - | $7.31 M(+4.7%) |
| Dec 2018 | $31.90 M(+38.7%) | $6.98 M(-6.9%) |
| Sept 2018 | - | $7.50 M(-22.4%) |
| June 2018 | - | $9.66 M(+24.4%) |
| Mar 2018 | - | $7.76 M(+10.3%) |
| Dec 2017 | $23.01 M(+26.6%) | $7.04 M(+9.6%) |
| Sept 2017 | - | $6.43 M(+29.8%) |
| June 2017 | - | $4.95 M(+7.9%) |
| Mar 2017 | - | $4.59 M(+3.2%) |
| Dec 2016 | $18.17 M(+40.9%) | $4.45 M(+5.1%) |
| Sept 2016 | - | $4.23 M(-23.7%) |
| June 2016 | - | $5.55 M(+40.9%) |
| Mar 2016 | - | $3.94 M |
| Dec 2015 | $12.89 M | - |
FAQ
- What is Aileron Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Aileron Therapeutics?
- What is Aileron Therapeutics annual operating expenses year-on-year change?
- What is Aileron Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Aileron Therapeutics?
- What is Aileron Therapeutics quarterly operating expenses year-on-year change?
What is Aileron Therapeutics annual total operating expenses?
The current annual operating expenses of ALRN is $15.35 M
What is the all time high annual operating expenses for Aileron Therapeutics?
Aileron Therapeutics all-time high annual total operating expenses is $31.90 M
What is Aileron Therapeutics annual operating expenses year-on-year change?
Over the past year, ALRN annual total operating expenses has changed by -$12.30 M (-44.49%)
What is Aileron Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of ALRN is $6.07 M
What is the all time high quarterly operating expenses for Aileron Therapeutics?
Aileron Therapeutics all-time high quarterly total operating expenses is $9.66 M
What is Aileron Therapeutics quarterly operating expenses year-on-year change?
Over the past year, ALRN quarterly total operating expenses has changed by +$4.09 M (+207.08%)